These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 7842499)
1. Ontogeny of neuropeptide FF pharmacology and receptors in mouse brain. Desprat C; Zajac JM Brain Res Dev Brain Res; 1994 Oct; 82(1-2):118-26. PubMed ID: 7842499 [TBL] [Abstract][Full Text] [Related]
2. Anti-opioid efficacy of neuropeptide FF in morphine-tolerant mice. Gelot A; Francés B; Roussin A; Latapie JP; Zajac JM Brain Res; 1998 Oct; 808(2):166-73. PubMed ID: 9767158 [TBL] [Abstract][Full Text] [Related]
3. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues. Gouardères C; Jhamandas K; Sutak M; Zajac JM Br J Pharmacol; 1996 Feb; 117(3):493-501. PubMed ID: 8821539 [TBL] [Abstract][Full Text] [Related]
4. Dissociation of pharmacological pro- and anti-opioid effects by neuropeptide FF analogs. Quelven I; Roussin A; Burlet-Schiltz O; Gouardères C; Tafani JA; Mazarguil H; Zajac JM Eur J Pharmacol; 2002 Aug; 449(1-2):91-8. PubMed ID: 12163111 [TBL] [Abstract][Full Text] [Related]
5. Effects of neuropeptide FF analogs on morphine analgesia in the nucleus raphe dorsalis. Dupouy V; Zajac JM Regul Pept; 1995 Nov; 59(3):349-56. PubMed ID: 8577940 [TBL] [Abstract][Full Text] [Related]
6. Role of adenosine in the spinal antinociceptive and morphine modulatory actions of neuropeptide FF analogs. Gouardères C; Sutak M; Zajac JM; Jhamandas K Eur J Pharmacol; 2000 Oct; 406(3):391-401. PubMed ID: 11040346 [TBL] [Abstract][Full Text] [Related]
7. Spinal effect of a neuropeptide FF analogue on hyperalgesia and morphine-induced analgesia in mononeuropathic and diabetic rats. Courteix C; Coudoré-Civiale MA; Privat AM; Zajac JM; Eschalier A; Fialip J Br J Pharmacol; 1999 Jul; 127(6):1454-62. PubMed ID: 10455296 [TBL] [Abstract][Full Text] [Related]
8. Structure-activity study of neuropeptide FF: contribution of N-terminal regions to affinity and activity. Gicquel S; Mazarguil H; Desprat C; Allard M; Devillers JP; Simonnet G; Zajac JM J Med Chem; 1994 Oct; 37(21):3477-81. PubMed ID: 7932576 [TBL] [Abstract][Full Text] [Related]
9. Functional consequences of neuropeptide FF receptors stimulation in mouse: a cerebral glucose uptake study. Quelven I; Roussin A; Zajac JM Neuroscience; 2004; 126(2):441-9. PubMed ID: 15207362 [TBL] [Abstract][Full Text] [Related]
10. Neuropeptide FF receptors control morphine-induced analgesia in the parafascicular nucleus and the dorsal raphe nucleus. Dupouy V; Zajac JM Eur J Pharmacol; 1997 Jul; 330(2-3):129-37. PubMed ID: 9253945 [TBL] [Abstract][Full Text] [Related]
11. Dual localization of neuropeptide FF receptors in the rat dorsal horn. Gouardères C; Roumy M; Advokat C; Jhamandas K; Zajac JM Synapse; 2000 Jan; 35(1):45-52. PubMed ID: 10579807 [TBL] [Abstract][Full Text] [Related]
12. Quantitative autoradiographic distribution of NPFF1 neuropeptide FF receptor in the rat brain and comparison with NPFF2 receptor by using [125I]YVP and [(125I]EYF as selective radioligands. Gouardères C; Quelven I; Mollereau C; Mazarguil H; Rice SQ; Zajac JM Neuroscience; 2002; 115(2):349-61. PubMed ID: 12421602 [TBL] [Abstract][Full Text] [Related]
13. Neuropeptide FF receptors: structure-activity relationship and effect of morphine. Payza K; Akar CA; Yang HY J Pharmacol Exp Ther; 1993 Oct; 267(1):88-94. PubMed ID: 8229791 [TBL] [Abstract][Full Text] [Related]
14. Central administration of neuropeptide FF and related peptides attenuate systemic morphine analgesia in mice. Fang Q; Jiang TN; Li N; Han ZL; Wang R Protein Pept Lett; 2011 Apr; 18(4):403-9. PubMed ID: 21121889 [TBL] [Abstract][Full Text] [Related]
15. Effects of neuropeptide FF and related peptides on the antinociceptive activities of VD-hemopressin(α) in naive and cannabinoid-tolerant mice. Pan JX; Wang ZL; Li N; Zhang N; Wang P; Tang HH; Zhang T; Yu HP; Zhang R; Zheng T; Fang Q; Wang R Eur J Pharmacol; 2015 Nov; 767():119-25. PubMed ID: 26472125 [TBL] [Abstract][Full Text] [Related]
16. Neuropeptide FF, pain and analgesia. Roumy M; Zajac JM Eur J Pharmacol; 1998 Mar; 345(1):1-11. PubMed ID: 9593588 [TBL] [Abstract][Full Text] [Related]
17. [(125)I]EYF: a new high affinity radioligand to neuropeptide FF receptors. Gouardères C; Mollereau C; Tafani JA; Mazarguil H; Zajac JM Peptides; 2001 Apr; 22(4):623-9. PubMed ID: 11311733 [TBL] [Abstract][Full Text] [Related]
18. Neuropeptide FF receptors in rat brain: a quantitative light-microscopic autoradiographic study using [125I][D.Tyr1, (NMe)Phe3]NPFF. Dupouy V; Zajac JM Synapse; 1996 Nov; 24(3):282-96. PubMed ID: 8923669 [TBL] [Abstract][Full Text] [Related]
19. Cholera and pertussis toxins inhibit differently hypothermic and anti-opioid effects of neuropeptide FF. Francés B; Lahlou H; Zajac JM Regul Pept; 2001 Apr; 98(1-2):13-8. PubMed ID: 11179773 [TBL] [Abstract][Full Text] [Related]
20. Differential modulation of alpha 2-adrenergic and mu-opioid spinal antinociception by neuropeptide FF. Kontinen VK; Kalso EA Peptides; 1995; 16(5):973-7. PubMed ID: 7479344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]